Status:
COMPLETED
Study to Assess Safety, Tolerability and Pharmacokinetics After Single Doses of AZD1446 to Healthy Volunteers
Lead Sponsor:
AstraZeneca
Conditions:
Healthy
Eligibility:
All Genders
18-50 years
Phase:
PHASE1
Brief Summary
The primary purpose of this study is to assess the safety and tolerability of AZD1446 following single dose administration.
Eligibility Criteria
Inclusion
- physical healthy volunteers
- weight between 50 to 100 kg and a body mass index (BMI) between 19 and 30 kg/m2
Exclusion
- History of any clinically significant disease or disorder.
- History of severe allergy/hypersensitivity reactions
Key Trial Info
Start Date :
December 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2009
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT00803855
Start Date
December 1 2008
End Date
April 1 2009
Last Update
May 15 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research site
Huddinge, Sweden